文献速递牙周病

年龄对釉基质蛋白衍生物牙周再生治疗3年疗效的影响

Influence of aging on periodontal regenerative therapy using enamel matrix derivative: A 3-year prospective cohort study.
PubMed 文献 · J Clin Periodontol · 2021-10-25

这项前瞻性队列研究纳入151例患者共253个骨下缺损,评估年龄对釉基质蛋白衍生物(EMD)牙周再生治疗3年结局的影响。1年时年龄与探诊深度和临床附着获得呈显著负相关,但3年时年龄与所有结局均无显著关联,各年龄组均获得显著临床改善。

要点

  • EMD牙周再生治疗在3年观察中显著改善PD、CAL和骨缺损深度。
  • 1年时年龄与PD和CAL改善呈负相关,每增加10岁分别少改善0.13mm和0.23mm。
  • 3年时年龄与PD、CAL或RBD改善均无显著关联。

核心结论

  • 尽管1年检查时检测到年龄与改善的统计学差异,但长期观察中EMD牙周再生治疗显著改善临床结局,与患者年龄无关。

研究设计与样本

  • 前瞻性队列研究,纳入151例患者共253个骨下缺损(含44个根分叉病变),再生治疗后随访3年。
  • 采用多水平回归分析评估年龄对结局的影响,并校正混杂因素。

主要发现

  • 患者平均年龄55.9±12.3岁(范围22-85岁),基线PPD、CAL和RBD分别为6.14±1.82、7.22±2.14和5.08±2.04 mm。
  • 1年和3年检查时PPD分别减少2.84±1.73和2.87±1.87 mm,CAL分别获得2.40±1.87和2.47±1.89 mm,RBD分别获得1.76±1.98和2.39±2.41 mm。
  • 1年检查时多变量分析显示年龄与PPD和CAL改善呈显著负相关(系数:每10年-0.13、-0.23 mm)。
  • 3年检查时年龄与PPD、CAL或RBD改善均无显著关联。

临床怎么用

  • EMD牙周再生治疗可显著改善骨下缺损的临床和影像学结局,长期疗效不受年龄影响。
  • 老年患者也可预期获得与年轻患者相似的3年再生治疗效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To investigate the influence of chronological aging on periodontal regenerative therapy (PRT) outcomes with enamel matrix derivative (EMD). MATERIALS AND METHODS: In total, 253 intra-bony defects (151 patients) including 44 furcation involvement were prospectively investigated for 3 years after regenerative therapy with EMD by evaluating probing pocket depth (PPD), clinical attachment level (CAL), and radiographic bone defect depth (RBD). The influence of age on these outcomes was assessed using multilevel regression analyses adjusting for confounders. RESULTS: Participants' mean age was 55.9 ± 12.3 years (range: 22-85). Baseline PPD, CAL, and RBD were 6.14 ± 1.82, 7.22 ± 2.14, and 5.08 ± 2.04 mm, respectively. Significant improvement was observed with PPD reductions of 2.84 ± 1.73 and 2.87 ± 1.87 mm, CAL gains of 2.40 ± 1.87 and 2.47 ± 1.89 mm, and RBD gains of 1.76 ± 1.98 and 2.39 ± 2.41 mm at 1- and 3-year examinations, respectively. At the 1-year examination, multivariate analysis revealed a significant negative association between age and improvement in PPD and CAL (coefficients: -0.13, -0.23 mm per 10 years). However, by the 3-year examination, no significant association was noted between age and improvement in PPD, CAL, or RBD. CONCLUSION: Although the statistical difference was detected with age at 1-year examination, PRT with EMD significantly improved clinical outcomes on long-term observation, irrespective of the patient's age. CLINICAL TRIAL REGISTRATION NUMBER: UMIN000039846.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Mikami R, Mizutani K, Shioyama H, et al. Influence of aging on periodontal regenerative therapy using enamel matrix derivative: A 3-year prospective cohort study. J Clin Periodontol. 2021. PMID: 34545600. doi:10.1111/jcpe.13552

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。